LDC1267
CAS No. 1361030-48-9
LDC1267( LDC1267 | LDC-1267 | LDC 1267 )
Catalog No. M17256 CAS No. 1361030-48-9
LDC1267 is a excellently specific TAM(Tyro3, Axl and Mer) kinase inhibitor, for Mer( IC50<5 nM), Tyro3(IC50=8 nM), and Axl(IC50=29 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 81 | In Stock |
|
| 2MG | 42 | In Stock |
|
| 5MG | 67 | In Stock |
|
| 10MG | 102 | In Stock |
|
| 25MG | 168 | In Stock |
|
| 50MG | 243 | In Stock |
|
| 100MG | 410 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLDC1267
-
NoteResearch use only, not for human use.
-
Brief DescriptionLDC1267 is a excellently specific TAM(Tyro3, Axl and Mer) kinase inhibitor, for Mer( IC50<5 nM), Tyro3(IC50=8 nM), and Axl(IC50=29 nM).
-
DescriptionLDC1267 is a potent and selective TAM kinase inhibitor. LDC1267 displays lower activity against Met, Aurora B, Lck, Src, and CDK8. LDC1267 markedly reduced murine mammary cancer and melanoma metastases dependent on NK cells. The TAM tyrosine kinase receptors Tyro3, Axl and Mer (also known as Mertk) were identified as ubiquitylation substrates for Cbl-b. Treatment of wild-type NK cells with a newly developed small molecule TAM kinase inhibitor conferred therapeutic potential, efficiently enhancing anti-metastatic NK cell activity in vivo.
-
In Vitro——
-
In VivoAnimal Model:C57BL/6J wild type mice (8-12 weeks old syngeneic bearing B16F10 cells) Dosage:20mg/kg Administration:Intraperitoneal injection; every 12 hours for 14 daysResult:Markedly reduced metastatic spreading of melanomas.
-
SynonymsLDC1267 | LDC-1267 | LDC 1267
-
PathwayCell Cycle/DNA Damage
-
TargetPLK
-
RecptorAXL| Mer| Tyro3
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number1361030-48-9
-
Formula Weight560.55
-
Molecular FormulaC30H26F2N4O5
-
Purity>98% (HPLC)
-
SolubilityDMSO : 50 mg/mL. 89.20 mM; H2O : < 0.1 mg/mL
-
SMILESc1(c(cc2c(c1)c(ccn2)Oc1ccc(cc1F)NC(=O)c1nn(cc1OCC)c1ccc(cc1C)F)OC)OC
-
Chemical NameN-[4-[(6,7-dimethoxy-4-quinolyl)oxy]-3-fluoro-phenyl]-4-ethoxy-1-(4-fluoro-2-methyl-phenyl)pyrazole-3-carboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Paolino M, et al. Nature. 2014, 507(7493), 508-512.
molnova catalog
related products
-
Volasertib
Volasertib (BI 6727) is a potent, selective Polo-like kinase (PLK) inhibitor with IC50 of 0.87, 5 and 56 nM for PLK1, 2 and 3, respectively.
-
3MB-PP1
3MB-PP1 is an inhibitor of Polo-like kinase 1 (PLK1) and inhibits Leu93 Mutant Zipper-interacting protein kinase (Leu93-ZIPK) with an IC50 of 2 μM.
-
Plogosertib
Plogosertib (CYC140) is an orally active, selective, potent, and ATP-competitive PLK1 inhibitor with an IC50 value of 3 nM.
Cart
sales@molnova.com